Clinical Trial Update: Quality of Life After Hyperbaric Oxygen Therapy in Post-COVID Patients

View source ↗

Summary

This document provides an update on a clinical trial evaluating quality of life after hyperbaric oxygen therapy in patients with long COVID.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Rutger Lalieu | Conditions: Long COVID, Long COVID-19 Syndrome | Status: ACTIVE_NOT_RECRUITING